Can Cao

8PUBLICATIONS
26CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologiesSensor technology (incl. chemical aspects)Biomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 09, 2026
Development of a clinically viable MRGPRX4 inverse agonist for cholestatic itch treatment.

Jun Yang, Ruichao Shen, Chunyu Wang

|May 08, 2024
MRGPRX4 mediates phospho-drug-associated pruritus in a humanized mouse model.

Daphne Chun-Che Chien, Nathachit Limjunyawong, Can Cao

|Apr 10, 2024
Bitter taste receptor activation by cholesterol and an intracellular tastant.

Yoojoong Kim, Ryan H Gumpper, Yongfeng Liu

|Nov 30, 2022
Molecular basis for selective activation of DREADD-based chemogenetics.

Shicheng Zhang, Ryan H Gumpper, Xi-Ping Huang

|Oct 27, 2022
Ligand recognition and allosteric modulation of the human MRGPRX1 receptor.

Yongfeng Liu, Can Cao, Xi-Ping Huang

Pageof 2